Florian Marx, PhD

Research Fellow

Research theme: Combatting Infections of National Priority

Dr. Florian Marx is a Senior Researcher at SACEMA and the Desmond Tutu TB Centre (DTTC), Faculty of Medicine and Health Sciences of Stellenbosch University. He coordinates a joint SACEMA-DTTC Tuberculosis Modelling Partnership and Research Programme and leads the Working Group Data Analysis and Modelling (WGDAM). Before joining SACEMA, he received a PhD degree at Stellenbosch University (2018) and completed a research fellowship at Harvard Medical School (2014) and Yale School of Public Health (2015-16). He received a Masters Degree in Epidemiology from the London School of Hygiene and Tropical Medicine (2009) and a Medical Degree from Charite Berlin (2007). His research focusses on the epidemiology of tuberculosis and the public health impact of TB control interventions with a particular focus on high-incidence settings.

ORCID ID: 0000-0003-4630-4598

Recent publications

Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis
Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G

The Lancet Global Health

(2020)

https://doi.org/10.1016/S2214-109X(20)30227-8
Post-tuberculosis lung health: perspectives from the First International Symposium
Allwood BW, van der Zalm MM, Amaral AFS, Byrne A, Datta S, Egere U, Evans CA, Evans D, Gray DM, Hoddinott G, Ivanova O, Jones R, Makanda G, Marx FM, Meghji J, Mpagama SG, Pasipanodya JG, Rachow A, Schoeman I, Shaw J, Stek C, van Kampen S, von Delft D, Walker NF, Wallis RS, Mortimer K

The International Journal of Tuberculosis and Lung Disease

(2020)

https://doi.org/10.5588/ijtld.20.0067
Inference of naturally-acquired immunity using a self-matched negative control design
Graham RN, Qian L, Bruxvoort K, Marx FM, Whittles LK, Lewnard J

Epidemiology

(2020)

https://doi.org/10.1097/EDE.0000000000001305
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson GJ, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G

The Lancet Respiratory Medicine

(2020)

https://doi.org/10.1016/S2213-2600(19)30370-4
Post-tuberculosis mortality and morbidity: valuing the hidden epidemic
Quaife M, Houben RMJ, Allwood BW, Cohen T, Coussens AK, Harries AD, Marx FM, Sweeney S, Wallis RS, Menzies NA

The Lancet Respiratory Medicine

(2020)

https://doi.org/10.1016/S2213-2600(20)30039-4
Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa
Marx FM, Cohen T, Lombard C, Hesseling AC, Dlamini SS, Beyers N, Naidoo P

The International Journal of Tuberculosis and Lung Disease

(2019)

https://doi.org/10.5588/ijtld.18.0609
Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting
Dippenaar A, De Vos M, Marx FM, Adroub SA, van Helden PD, Pain A, Sampson SL, Warren RM

Infection, Genetics and Evolution

(2019)

https://doi.org/10.1016/j.meegid.2019.103948
Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study
Osman M, Welte A, Dunbar R, Brown R, Hoddinott G, Hesseling AC, Marx FM

International Journal of Infectious Diseases

(2019)

https://doi.org/10.1016/j.ijid.2019.05.024
The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study
Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy G, van Helden PD, Beyers N

Clinical Infectious Diseases

(2014)

https://doi.org/10.1093/cid/ciu186
Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa
Osman M, Meehan S, Von Delft A, Du Preez K, Dunbar R, Marx FM, Boulle A, Welte A, Naidoo P, Hesseling AC

PLOS ONE

(2021)

https://doi.org/10.1371/Journal.pone.0252084